Acute cognitive effects of standardised Ginkgo biloba extract complexed with phosphatidylserine

Recent data suggest that the complexation of standardised Ginkgo biloba extract (GBE) with soy‐derived phospholipids enhances the bio‐availablity of GBE's active components. The current study therefore aimed to assess the comparative cognitive and mood effects of a low dose of GBE and products complexing the same extract with either phosphatidylserine or phosphatidylcholine.

[1]  K. Nakanishi,et al.  Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation. , 2002, Journal of medicinal chemistry.

[2]  J. Krieglstein,et al.  Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. , 1988, Pharmacological research communications.

[3]  D. Kennedy,et al.  Acute, dose‐dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand , 2002, Human psychopharmacology.

[4]  A. Mendelow,et al.  Extracts of Ginkgo biloba and Panax ginseng protect brain proteins from free radical induced oxidative damage in vitro. , 2000, Acta neurochirurgica. Supplement.

[5]  C. Scali,et al.  Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. , 1991, European journal of pharmacology.

[6]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[7]  Z. Krištofíková,et al.  In vitro effect of Ginkgo biloba extract (EGb 761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus. , 1997, Dementia and geriatric cognitive disorders.

[8]  K. Wesnes,et al.  The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers , 2000, Psychopharmacology.

[9]  M. Droy-lefaix.  Effect of the antioxidant action of Ginkgo biloba extract (EGb 761) on aging and oxidative stress , 1997, AGE.

[10]  I. Hindmarch,et al.  The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers , 1999, Phytotherapy research : PTR.

[11]  E. Weiller,et al.  [Comparative effects of ginkgo biloba extracts on psychomotor performances and memory in healthy subjects]. , 1991, Therapie.

[12]  G. Keppel.  Design and analysis: A researcher's handbook, 3rd ed. , 1991 .

[13]  S. Tufik,et al.  Phosphatidylserine reverses reserpine-induced amnesia. , 2000, European journal of pharmacology.

[14]  D. Kennedy,et al.  Differential, Dose Dependent Changes in Cognitive Performance Following Acute Administration of a Ginkgo biloba/Panax ginseng Combination to Healthy Young Volunteers , 2001, Nutritional neuroscience.

[15]  S. Akiba,et al.  Inhibitory effect of the leaf extract of Ginkgo biloba L. on oxidative stress‐induced platelet aggregation , 1998, Biochemistry and molecular biology international.

[16]  F. Jung,et al.  Effect of Ginkgo biloba on fluidity of blood and peripheral microcirculation in volunteers. , 1990, Arzneimittel-Forschung.

[17]  D. Kennedy,et al.  The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers , 2000, Psychopharmacology.

[18]  J. Krieglstein,et al.  Influence of an extract of Ginkgo biloba on cerebral blood flow and metabolism. , 1986, Life sciences.

[19]  P. Mauri,et al.  Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of terpene lactones in plasma of animals. , 2003, Journal of pharmaceutical and biomedical analysis.

[20]  R. Ritch,et al.  Ginkgo biloba extract increases ocular blood flow velocity. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[21]  M. Giovannini,et al.  The brain cholinergic system as a target of cognition enhancers , 1997, Behavioural Brain Research.

[22]  K. W. Kallus,et al.  How should we measure nutrition-induced improvements in memory? , 2005, European journal of nutrition.

[23]  R. Schloegl.  Energy: Fuel for thought. , 2008, Nature materials.

[24]  E. Perry,et al.  Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) , 2002, Pharmacology Biochemistry and Behavior.

[25]  Megan E. Pahmier,et al.  Double Blind , 2001, International Psychogeriatrics.

[26]  C. Gardana,et al.  Liquid chromatography/atmospheric pressure chemical ionization mass spectrometry of terpene lactones in plasma of volunteers dosed with Ginkgo biloba L. extracts. , 2001, Rapid communications in mass spectrometry : RCM.

[27]  D. Kennedy,et al.  Cognitive demand and blood glucose , 2001, Physiology & Behavior.

[28]  I. Hindmarch.  [Activity of Ginkgo biloba extract on short-term memory]. , 1986, Presse medicale.

[29]  B. Leupen,et al.  Design and analysis , 1997 .

[30]  A. Bruni,et al.  Lysophosphatidylserine, a short-lived intermediate with plasma membrane regulatory properties. , 1982, Pharmacological research communications.

[31]  J. Vance,et al.  Metabolism and functions of phosphatidylserine. , 2005, Progress in lipid research.

[32]  D. Williams,et al.  Stabilization of the peripheral-type benzodiazepine acceptor by specific phospholipids. , 1992, Biochemical pharmacology.

[33]  A. Bond,et al.  The use of analogue scales in rating subjective feelings , 1974 .

[34]  K. I. Maynard,et al.  Acute administration of Ginkgo biloba extract (EGb 761) affords neuroprotection against permanent and transient focal cerebral ischemia in Sprague‐Dawley rats , 2002, Journal of neuroscience research.

[35]  R. H. Silva,et al.  Bovine Brain Phosphatidylserine Attenuates Scopolamine-induced Amnesia , 1999, Physiology & Behavior.

[36]  M. Poelman,et al.  In‐vivo and In‐vitro Assessment of the Free‐radical‐scavenger Activity of Ginkgo Flavone Glycosides at High Concentration , 1999, The Journal of pharmacy and pharmacology.

[37]  K. Drieu,et al.  Decreased cerebral 5‐HT1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761) , 1994, The Journal of pharmacy and pharmacology.

[38]  R. Wurtman,et al.  Phosphatidylcholine as a precursor of choline for acetylcholine synthesis. , 1987, Journal of neural transmission. Supplementum.

[39]  J. Taylor.  [Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract]. , 1986, Presse medicale.

[40]  D. Kennedy,et al.  Modulation of cognition and mood following administration of single doses of Ginkgo biloba, ginseng, and a ginkgo/ginseng combination to healthy young adults , 2002, Physiology & Behavior.

[41]  J. Remacle,et al.  Protection of mitochondrial respiration activity by bilobalide. , 1999, Biochemical pharmacology.

[42]  J. Jolles,et al.  Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS. , 1999, Nutrition.

[43]  S. Rachman,et al.  The effects of blood sugar level changes on cognitive function, affective state, and somatic symptoms , 1988, Journal of Behavioral Medicine.

[44]  B. Tavolato,et al.  Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL) , 2004, Journal of Neurology.

[45]  J. Mix,et al.  A double‐blind, placebo‐controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings , 2002, Human psychopharmacology.

[46]  J. Kleijnen,et al.  Ginkgo biloba , 1992, The Lancet.

[47]  P. Kidd.  A review of nutrients and botanicals in the integrative management of cognitive dysfunction. , 1999, Alternative medicine review : a journal of clinical therapeutic.

[48]  S. Yamamoto,et al.  Administration of phosphatidylcholine increases brain acetylcholine concentration and improves memory in mice with dementia. , 1995, The Journal of nutrition.

[49]  Michael J. Stasio,et al.  Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats , 1989, Experimental Neurology.

[50]  Taylor Je.  Neuromediator binding to receptors in the rat brain. The effect of chronic administration of Ginkgo biloba extract , 1986 .

[51]  J. Mix,et al.  An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. , 2000, Journal of alternative and complementary medicine.

[52]  L. Amaducci,et al.  A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? , 1996, Pharmacological research.

[53]  S. Chatterjee,et al.  Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba , 1997, Brain Research.

[54]  P. Nathan,et al.  Neuropsychological changes after 30-day Ginkgo biloba administration in healthy participants. , 2001, The international journal of neuropsychopharmacology.

[55]  M. Hayman.  TWO MINUTE CLINICAL TEST FOR MEASUREMENT OF INTELLECTUAL IMPAIRMENT IN PSYCHIATRIC DISORDERS , 1942 .

[56]  G. Aldini,et al.  Complexation of Ginkgo biloba extract with phosphatidylcholine improves cardioprotective activity and increases the plasma antioxidant capacity in the rat. , 2001, Planta medica.

[57]  L. Parnetti,et al.  Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? , 2001, Mechanisms of Ageing and Development.

[58]  K. Tan-No,et al.  Effects of ginkgo biloba extract on impairment of learning induced by cerebral ischemia in mice. , 1998, The American Journal of Chinese Medicine.

[59]  S. Mazzari,et al.  Modification of noradrenergic hypothalamic system in rat injected with phosphatidylserine liposomes. , 1978, Life sciences.

[60]  D. Guidolin,et al.  Dendritic spine loss in hippocampus of aged rats. Effect of brain phosphatidylserine administration , 1987, Neurobiology of Aging.

[61]  Paul F. Smith,et al.  The neuroprotective properties of the Ginkgo biloba leaf: a review of the possible relationship to platelet-activating factor (PAF). , 1996, Journal of ethnopharmacology.

[62]  S. Cohen,et al.  Age-related alterations of NMDA-receptor properties in the mouse forebrain: partial restoration by chronic phosphatidylserune treatment , 1992, Brain Research.

[63]  K. Wesnes,et al.  A double‐blind placebo‐controlled trial of tanakan in the treatment of idiopathic cognitive impairment in the elderly , 1987 .

[64]  R. Cuppini,et al.  Regeneration of motor nerves in bilobalide-treated rats. , 1993, Planta medica.

[65]  P. Solomon,et al.  Ginkgo for memory enhancement: a randomized controlled trial. , 2002, JAMA.

[66]  J. Birks,et al.  Ginkgo biloba for cognitive impairment and dementia (Review) , 2017 .

[67]  M. McDaniel,et al.  “Brain-Specific” Nutrients: A Memory Cure? , 2002, Psychological science in the public interest : a journal of the American Psychological Society.

[68]  P. Mauri,et al.  Liquid chromatography/electrospray mass spectrometry of bioactive terpenoids in Ginkgo biloba L. , 1999, Journal of mass spectrometry : JMS.

[69]  D. Kennedy,et al.  Dose Dependent Changes in Cognitive Performance and Mood following Acute Administration of Ginseng to Healthy Young Volunteers , 2001, Nutritional neuroscience.

[70]  Y. Christen,et al.  The Ginkgo biloba extract, EGb761, increases synaptosomal uptake of 5‐hydroxytryptamine: in‐vitro and ex‐vivo studies , 1992, The Journal of pharmacy and pharmacology.